Background
Human herpesvirus 8 (HHV-8) has been detected in all epidemiological forms of Kaposi sarcoma (KS). The role of HHV-8 in dermatologic diseases other than KS is controversial. Some studies based on polymerase chain reaction findings suggest an association between HHV-8 and epithelial tumors of the skin, lymphoproliferative disorders, or pemphigus.
Objective
To assess the prevalence of antibodies against a latent nuclear antigen of HHV-8 in patients with various dermatologic diseases.
Design
An indirect immunofluorescence assay was used to search for HHV-8 antibodies.
Setting
Ambulatory or hospitalized patients from a university hospital associated with a research laboratory.
Patients
Eighty-three patients with various non-KS dermatologic diseases and 16 patients with KS who were seronegative for the human immunodeficiency virus. Controls were 100 healthy subjects living in the same area.
Results
Antibodies to HHV-8 were found in 100% (16/16) of the patients with KS and 3.6% (3/83) of the patients with non-KS dermatologic diseases: 1 patient with pemphigus vulgaris, 1 with discoid lupus erythematosus, and 1 with bullous pemphigoid. The prevalence of antibodies to HHV-8 in controls was 2% (2/100) and was not significantly different than the prevalence in patients with dermatologic diseases other than KS (P=.28).
Conclusions
Our serologic study confirms the higher prevalence of HHV-8 antibodies in patients with KS and demonstrates that contrary to other human herpesviruses, HHV-8 is not a ubiquitous virus in France. We could not determine any causal association between HHV-8 and pemphigus or lymphoproliferative disorders of the skin.
KAPOSI sarcoma (KS)–associated herpesvirus, also known as human herpesvirus 8 (HHV-8), is consistently found in all epidemiological forms of KS.1 Human herpesvirus 8 genomes are present in endothelial and spindle cells, the histological hallmark of KS.2 The frequency of detection of HHV-8 in other dermatologic diseases is controversial. Some authors report that HHV-8 may be found in other dermatologic diseases, such as epithelial tumors, cutaneous T-cell lymphoma, or pemphigus vulgaris, and that HHV-8 could be a widespread virus reactivated in some tumoral or immunological conditions.3-6 However, we and others7-11 have not confirmed the presence of HHV-8 in lymphoproliferative disorders of the skin or in epithelial tumors either in immunocompetent or immunosuppressed patients. Such discrepancies could reflect the variation of the distribution of HHV-8 infection by geographical area. Some serologic study results suggest that, at least in western countries, HHV-8 infection is largely confined to individuals with or at risk for KS.12-14 However, one study of antilytic HHV-8 antibodies suggests that the prevalence of HHV-8 could be as high as 25% in the general population in the United States.15 Nevertheless, using an antilytic assay cross-reactive against other human herpesviruses, notably Epstein-Barr virus (HHV-4), could lead to an overestimation of the prevalence of HHV-8 antibodies. The aim of our study was to assess the prevalence of antibodies against a latent nuclear antigen of HHV-8 in patients with various cutaneous diseases and to compare it with the prevalence in patients with KS and in healthy control subjects.
Serum samples were collected from 83 patients with various dermatologic diseases: cutaneous T-cell lymphoma (n=17), pseudolymphoma (n=4), B-cell lymphoma (n=1), anaplastic T-cell lymphoma (n=1), malignant melanoma (n=5), discoid lupus erythematosus (n=6), psoriasis (n=8), pemphigus (n=13, including 4 with pemphigus foliaceus and 9 with pemphigus vulgaris), vasculitis (n=5), erythema multiforme (n=4), bullous pemphigoid (n=11), and other dermatologic diseases (urticaria [n=2], pruritus [n=2], erythema nodosum [n=2], cutaneous sarcoidosis [n=1], and morphea [n=1]). We also studied serum samples from 14 patients with classic KS, including 2 homosexual patients with KS who were seronegative for the human immunodeficiency virus (HIV) and 3 partners of 3 patients with KS: 1 HIV-negative homosexual man whose partner was an HIV-negative homosexual man with stage I KS and 2 HIV-negative partners of 2 patients with stage I classic KS. Serum samples were collected at the patient's first visit or before the initiation of immunosuppressive therapy, except in 4 patients with autoimmune bullous diseases who were undergoing therapy with prednisone at a low level (5-20 mg/d). The samples were stored at −80°C until needed for processing. Serum samples from 100 healthy subjects served as controls.
Antibodies to a latent nuclear antigen (LNA-1) of HHV-8 were searched for using an immunofluorescence assay on a primary effusion cell line (BCP-1) latently infected with HHV-8 but not with the Epstein-Barr virus. The immunofluorescence assay was performed as previously described.10 Briefly, BCP-1 cells were fixed in 4% paraformaldehyde, rendered permeable with detergent (0.2% Triton × 100, Sigma-Aldrich, Dorset, England), incubated with human sera (1:100) for 30 minutes at room temperature, washed in a combined solution of phosphate-buffered saline and 3% fetal calf serum, incubated for 30 minutes with anti-human IgG–fluorescein isothiocyanate conjugate (Dako, Carpinteria, Calif), and then washed again and examined using fluorescence microscopy.
Antibodies to HHV-8 were found in the serum samples of all 14 patients with classic KS and in the 2 HIV-negative homosexual patients with KS. Antibodies to HHV-8 were also found in the serum samples of 3 tested partners of patients with KS. Serum samples of 2 (2%) of the 100 controls were found to be positive for HHV-8. Among the patients with dermatologic diseases, the prevalence of antibodies to HHV-8 was as follows: 0 (0%) of 23 patients with lymphoproliferative disorders of the skin, 0 (0%) of 5 patients with malignant melanoma, 1 (16%) of 6 patients with discoid lupus erythematosus, 0 (0%) of 8 patients with psoriasis, 1 (7%) of 13 patients with pemphigus, 0 (0%) of 5 patients with vasculitis, 0 (0%) of 4 patients with erythema multiforme, 1 (9%) of 11 patients with bullous pemphigoid, and 0 (0%) of the 8 patients with other dermatologic diseases. The prevalence of antibodies to HHV-8 in patients with dermatologic diseases other than KS was not statistically different than the prevalence in controls (3.6 % vs 2%, respectively; Fisher exact test, P=.28).
Our study was based on results of an immunofluorescence assay that detects antibodies against a latent nuclear antigen of HHV-8. This is the most sensitive and specific serologic assay available for determining past or present infection with this virus. The same serologic assay has enabled researchers to establish a strong correlation between HHV-8 infection and KS, to identify populations at risk for KS, and to question the pathogenic role of HHV-8 in multiple myeloma.16,17 Our results confirm that, in the area of Paris, France, HHV-8 is not a ubiquitous virus and is largely confined to patients with KS. The prevalence of antibodies to HHV-8 that we found in patients with KS is similar to the prevalence previously reported in such patients.12-15 Moreover, serologic studies provide explicit and confirmatory epidemiological data about HHV-8: the link between all epidemiological forms of KS and HHV-8; the preferential sexual transmission of this agent as suggested by a high prevalence in populations exposed to sexually transmitted diseases (eg, syphilis or HIV); and the restricted distribution in the general population in western countries and a higher prevalence in African countries.12-15 Thus, serologic assays give the best indication of prevalence of HHV-8. According to the findings of our serologic assay, the implication of HHV-8 in dermatologic diseases other than KS, such as cutaneous lymphoma or pemphigus, is uncommon. Previous studies based on findings of polymerase chain reaction suggest that HHV-8 could be implicated in the pathogenesis of epithelial tumors of the skin.3,6 However, these results have not been confirmed by other reports.7,8 Concerning the role of HHV-8 in lymphoproliferative disorders of the skin, one study reported the presence of HHV-8 DNA sequences in 7 of 48 cutaneous T-cell lymphomas, including 2 cases of mycosis fungoides, 2 peripheral T-cell lymphomas, 2 cases of parapsoriasis en plaque, and 1 lymphomatoid papulosis.4 These results were not confirmed in following studies, suggesting that HHV-8 is not directly implicated in the pathogenesis of either cutaneous T-cell or B-cell lymphoma.9-11 Results of our serologic study confirm the absence of any direct or indirect role of HHV-8 in the pathogenesis of lymphoproliferative disorders of the skin.
The role of HHV-8 in pemphigus vulgaris has been suspected in one case.5 Recently, HHV-8 DNA sequences were detected in 4 of 6 skin lesions from patients with pemphigus vulgaris and in all 6 skin lesions from patients with pemphigus foliaceus.18 These findings could not be explained by a cross-contamination of DNA according to the DNA sequencing analysis, and these results contrast with our own, which suggest that there is no link between HHV-8 and pemphigus. However, some argue that such discrepancies could result from the variation of the geographical distribution of HHV-8 infection. However, contrary to KS, which is associated with HHV-8 regardless of the patient's geographical origin, we could not determine any causative role of HHV-8 in pemphigus. Moreover, the presence of HHV-8 DNA sequences does not unambiguously signify that HHV-8 is directly implicated in the pathogenesis of pemphigus. In fact, this result could be explained by the presence of these sequences in the patients' peripheral blood mononuclear cells, which could have contaminated the skin samples. This hypothesis needs to be explored by further studies that compare HHV-8 DNA load in both lesional skin and normal skin in the same patient and include an evaluation of the presence of HHV-8 viremia.
The prevalence of antibodies to HHV-8 reported herein in healthy controls and in patients with non-KS dermatologic diseases is similar to the prevalence previously reported in the general population in western countries.12-14 Thus, our study reinforces the hypothesis of a link between HHV-8 and KS. Moreover, the fact that 3 partners of 3 different patients with KS were found to be seropositive for HHV-8 suggests that this virus could be sexually transmitted, as recently reported.19
In conclusion, using an immunofluorescence assay, we detected antibodies to a latent nuclear antigen of HHV-8, suggesting that contrary to other human herpesviruses, HHV-8 is not a widespread virus in France and that HHV-8 infection is limited to patients with or at risk for KS. Thus, we maintain that, HHV-8 is not involved in the pathogenesis of lymphoproliferative disorders of the skin or pemphigus.
Accepted for publication February 24, 1998.
This work was supported by grant 97020 from the Fondation Cancer et Solidarité and the Agence Nationale de Recherche Sur le Sida.
The primary effusion cell line BCP-1 was kindly provided by P. S. Moore, MD, School of Public Health, Columbia, NY. In addition, Irina Bournerias, MD, provided samples for our study.
We thank the nurses from Tarnier Hospital and Françoise Lamy, laboratory technician, for technical assistance.
Corresponding author: Nicolas Dupin, MD, Institute of Cancer Research, Virology Team, 237 Fulham Rd, London SW3 6JB, England.
1.Moore
PSChang
Y Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection.
N Engl J Med. 1995;3321181- 1185
Google ScholarCrossref 2.Boshoff
CSchulz
TFKennedy
MM
et al. Kaposi's sarcoma associated herpesvirus infects endothelial and spindle cells.
Nat Med. 1995;11274- 1278
Google ScholarCrossref 3.Rady
PLYen
ARollefson
JL
et al. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients.
Lancet. 1995;3451339- 1340
Google ScholarCrossref 4.Sander
CSimon
MPuchta
URaffeld
MKind
P HHV-8 in lymphoproliferative lesions in skin.
Lancet. 1996;348475- 476
Google ScholarCrossref 5.Memar
OMRady
PLGoldblum
RMTyring
SK Human herpesvirus-8 DNA sequences in a patient with pemphigus vulgaris, but without HIV infection or Kaposi's sarcoma.
J Invest Dermatol. 1997;108118- 119
Google ScholarCrossref 6.Nishimoto
SInagi
RYamanishi
KHosokawa
KKakibushi
MYoshikawa
K Prevalence of human herpesvirus-8 in skin lesions.
Br J Dermatol. 1997;137179- 184
Google ScholarCrossref 7.Boshoff
CTalbot
SKennedy
MO'Leary
JSchulz
TChang
Y HHV-8 and skin cancers in immunosuppressed patients.
Lancet. 1996;347338- 339
Google ScholarCrossref 8.Dupin
NGorin
IEscande
J-P
et al. Lack of evidence of any association between human herpesvirus 8 and various skin tumors from both immunocompetent and immunosuppressed patients [letter].
Arch Dermatol. 1997;133537
Google ScholarCrossref 9.Pawson
RCatovsky
DSchulz
TF Lack of evidence of HHV-8 in mature T-cell lymphoproliferative disorders.
Lancet. 1996;3481450- 1451
Google ScholarCrossref 10.Henghold
WBPurvis
SFSchaffer
JGiam
CZWood
GS No evidence of KSHV/HHV-8 in mycosis fungoides.
J Invest Dermatol. 1997;108920- 922
Google ScholarCrossref 11.Dupin
NFranck
NCalvez
V
et al. Detection of human herpesvirus 8 in HIV-negative patients with cutaneous lymphoma.
Br J Dermatol. 1997;136827- 830
Google ScholarCrossref 12.Simpson
GRSchulz
TFWhitby
D
et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
Lancet. 1996;3481133- 1138
Google ScholarCrossref 13.Gao
SJKingsley
LHoover
DR
et al. Seroconversion of antibodies to Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.
N Engl J Med. 1996;335233- 241
Google ScholarCrossref 14.Gao
SJKingsley
LLi
M
et al. KSHV antibodies among North Americans, Italians, and Ugandans with and without Kaposi's sarcoma.
Nat Med. 1996;2925- 928
Google ScholarCrossref 15.Lennette
ETBlackbourn
DJLevy
JA Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
Lancet. 1996;348858- 861
Google ScholarCrossref 17.Paraviccini
CLauri
EBaldini
L
et al. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma.
Science. 1997;2781969- 1973
Google ScholarCrossref 18.Memar
OMRady
PLGoldblum
RMYen
ATyring
SK Human herpesvirus 8 DNA sequences in blistering skin from patients with pemphigus.
Arch Dermatol. 1997;1331247- 1251
Google ScholarCrossref 19.Kedes
DHOperskalski
EBusch
M
et al. The seroprevalence of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in Kaposi's sarcoma risk group and evidence for sexual transmission.
Nat Med. 1996;2918- 924
Google ScholarCrossref